LMH STRATEGIC SOLUTIONS

Lobbying for GLAXOSMITHKLINE LLC · Pharmaceutical Company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 5, 2026

Lobbying activity 2

Health Issues

General health care coverage issues. Healthcare reform.

Pharmacy

Reimbursement issues for prescription drugs. Drug pricing reform. Vaccine Access. Food and Drug Administration legislative and regulatory issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.